rs7571895

Variant names:

• chr2-29528765-C-A
• rs7571895
• NM_004304.5:c.1154+3150G>T

Your query was ambiguous. Multiple possible variants found:

• chr2-29528765-C-A
• chr2-29528765-C-G
• chr2-29528765-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_004304.5(ALK):​c.1154+3150G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.562 in 151,990 control chromosomes in the GnomAD database, including 25,459 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.56 (25459 hom., cov: 31)
• Consequence: ALK NM_004304.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.0210
• Publications: 5 publications found

Genes affected

ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]

ALK Gene-Disease associations (from GenCC):

• neuroblastoma, susceptibility to, 3

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.87).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.664 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
ALK	NM_004304.5	c.1154+3150G>T		intron_variant	Intron 4 of 28	ENST00000389048.8	NP_004295.2
ALK	XR_001738688.3	n.2081+3150G>T		intron_variant	Intron 4 of 17

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
ALK	ENST00000389048.8	c.1154+3150G>T		intron_variant	Intron 4 of 28	1	NM_004304.5	ENSP00000373700.3
ALK	ENST00000618119.4	c.23+3150G>T		intron_variant	Intron 3 of 27	5		ENSP00000482733.1

Frequencies

GnomAD3 genomes AF: 0.562 AC: 85426 AN: 151874 Hom.: 25456 Cov.: 31

Gnomad AFR AF: 0.363

Gnomad AMI AF: 0.602

Gnomad AMR AF: 0.581

Gnomad ASJ AF: 0.630

Gnomad EAS AF: 0.595

Gnomad SAS AF: 0.418

Gnomad FIN AF: 0.645

Gnomad MID AF: 0.595

Gnomad NFE AF: 0.670

Gnomad OTH AF: 0.592

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.562 AC: 85450 AN: 151990 Hom.: 25459 Cov.: 31 AF XY: 0.557 AC XY: 41378 AN XY: 74274

African (AFR) AF: 0.363 AC: 15062 AN: 41480

American (AMR) AF: 0.581 AC: 8870 AN: 15276

Ashkenazi Jewish (ASJ) AF: 0.630 AC: 2181 AN: 3464

East Asian (EAS) AF: 0.594 AC: 3055 AN: 5140

South Asian (SAS) AF: 0.416 AC: 2001 AN: 4808

European-Finnish (FIN) AF: 0.645 AC: 6801 AN: 10552

Middle Eastern (MID) AF: 0.616 AC: 181 AN: 294

European-Non Finnish (NFE) AF: 0.670 AC: 45499 AN: 67950

Other (OTH) AF: 0.592 AC: 1251 AN: 2114

Alfa AF: 0.540 Hom.: 8708

Bravo AF: 0.550

Asia WGS AF: 0.559 AC: 1944 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.87
CADD	Benign	0.60
DANN	Benign	0.42
PhyloP100		-0.021
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs7571895; hg19: chr2-29751631;